What should I know about blood clot risk during Leukemia treatment

Blood Clot Risk During Leukemia Treatment

Blood clot risk is an important safety concern during leukemia treatment that you should understand and discuss with your care team.

Why Leukemia Patients Are at Higher Risk

According to the NCCN Guidelines for Patients: Acute Myeloid Leukemia, leukemia itself affects your body's ability to control bleeding and clotting. The guidelines explain that an impaired clotting process is common in leukemia—a condition called coagulopathy. This means:

• Your blood may not clot normally
• You may experience both bleeding problems AND clotting problems
• Certain leukemia treatments can further affect clotting

What Happens During Treatment

Several factors during leukemia treatment increase clot risk:

From the leukemia itself:

• Leukemia cells release substances that trigger abnormal clotting
• Damaged blood vessel linings from high blast counts
• Imbalances in clotting proteins

From treatment side effects:

• Chemotherapy can damage blood vessels
• Central lines (catheters) placed for treatment can trigger clots
• Reduced movement during intensive treatment
• Certain targeted therapies affect clotting factors

Screening and Monitoring

The NCCN Guidelines recommend that doctors perform blood clotting tests (called a coagulation panel or DIC panel) as standard screening. These tests check:

• How quickly your blood clots
• Levels of clotting proteins
• Signs of disseminated intravascular coagulation (DIC)—a serious clotting disorder

Your care team will monitor these tests regularly throughout treatment.

Signs to Watch For

Contact your healthcare team immediately if you notice:

• Unusual bruising (especially large or spreading bruises)
• Swelling, warmth, or redness in your legs or arms
• Shortness of breath or chest pain
• Severe headaches or vision changes
• Bleeding that won't stop (nosebleeds, bleeding gums, blood in urine or stool)

Questions to Ask Your Care Team

1. What is my specific clotting risk based on my leukemia subtype and treatment plan?
2. Will I need blood thinners or other medications to prevent clots?
3. What symptoms should I report immediately?
4. How often will my clotting function be tested during treatment?
5. Are there activities I should avoid or modify to reduce clot risk?
6. If I develop a clot, how would that change my treatment plan?

Important Context

Managing clotting risk is a balancing act—your doctors must prevent both dangerous clots AND dangerous bleeding. This is why regular monitoring is essential. Your care team will adjust your treatment and supportive care based on your individual clotting status.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.